Le Lézard
Classified in: Health, Business
Subjects: HEALTH, BOARD OF DIRECTORS, MISCELLANEOUS, MISCELLANEOUS, Management Changes

Qualifacts Names New Chief Revenue Officer


NASHVILLE, Tenn., May 17, 2023 (GLOBE NEWSWIRE) -- Qualifacts, a leading provider of electronic health record (EHR) platforms for behavioral health, rehabilitative, and human services organizations, recently announced that Mike Bursich has joined the company as the new Chief Revenue Officer.

"We are thrilled to welcome Mike to the Qualifacts team as our new CRO," said Scott Phillips, Qualifacts CEO. "We are innovating and growing rapidly, and we needed a leader with extensive healthcare sales and revenue experience. Mike not only has that expertise, but he also has the strategic vision and drive to take our organization to the next level."

As Chief Revenue Officer, Bursich is the driving force behind the overall revenue growth and Go-To-Market strategy for Qualifacts. Having over two decades of experience in healthcare and SaaS-based organizations, he has proven his capability in effectively managing revenue teams that thrive in diverse markets. Prior to this role, Bursich was Senior Vice President of Sales at Net Health, leading the Wound Care and Rehab Therapy sectors. During his tenure, he also demonstrated success in guiding Employee Health, Occupational Medicine, Clinical Trials, and Data Analytics through nine acquisitions.

"I am excited to join Qualifacts and the highly successful executive leadership team.  After spending the last two decades in the healthcare SaaS space, I have seen the growth and evolution of technology accelerate like never before. Not only is Behavioral Health one of the fastest-growing industries, but after seeing what the world has gone through over the last three years, the demand has never been higher. As one of the largest EHR companies in the country, Qualifacts is empowering caregivers to focus on improving the lives of the people they serve, and I am grateful to be an integral part of it," said Mike Bursich.

ABOUT QUALIFACTS 

Qualifacts is a leading provider of behavioral health software and SaaS solutions for clinical productivity, compliance and state reporting, billing, and business intelligence. Its mission is to be an innovative and trusted technology and end-to-end solutions partner, enabling exceptional outcomes for its customers and those they serve. Qualifacts' comprehensive portfolio, including the CareLogic®, Credibletm, and InSync® platforms, spans and serves the entire behavioral health, rehabilitative, and human services market supporting non-profit Certified Community Behavioral Health Clinics (CCBHC) as well as for-profit large enterprise and small business providers.  Qualifacts has a loyal customer base, with more than 2,500 customers representing 75,000 providers serving more than 6 million patients. Qualifacts was recognized in the 2022 and 2023 Best in KLAS: Software and Services report as having the top ranked Behavioral Health EHR solutions.  

 



These press releases may also interest you

at 09:18
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...

10 mai 2024
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...



News published on and distributed by: